Latest Breaking News On - Outstanding share - Page 9 : comparemela.com

New federal tax on share repurchases may cool efforts or become another accepted cost

Corporate America and investors enter a new financial era Sunday in which most share repurchases will be accompanied by a 1% federal tax on publicly traded corporations.

New yorkUnited statesMichael waldenRon wydenWilliam rogersTom harringtonHaynes booneSherrod brownZagros madjd sadjadiNc state universityImperial brands plcHayward industries incTruist financial corpCaterpillar incHanesbrands incReynolds american inc

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2022

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaAstella xtandiPhilip kantoffDavid parkinsonJanssen researchPharma incProstate cancer foundationCorporate highlightsCancer foundationAsed chimeraMolecular targetsOutstanding shareFast trackPrivate securities litigation reform actEssa pharma inc

Zomedica Announces Third Quarter 2022 Financial Results: $4 78 Million Revenue; 75% Gross Margin & $158 49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities

Zomedica Announces Third Quarter 2022 Financial Results: $4 78 Million Revenue; 75% Gross Margin & $158 49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Ann arborUnited statesLarry heatonAssisi animal healthZomedica corpChief executive officerPulse veterinary technologiesCalmer canineSmall animal veterinariansAnimal veterinarianThird quarterOutstanding shareRelations contactUnited states wire group

Zomedica Announces Third Quarter 2022 Financial Results: $4 78 Million Revenue; 75% Gross Margin & $158 49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities

Zomedica Announces Third Quarter 2022 Financial Results: $4 78 Million Revenue; 75% Gross Margin & $158 49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Zomedica Corp : Zomedica Announces Third Quarter 2022 Financial Results: $4 78 Million Revenue; 75% Gross Margin & $158 49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities

ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company", a veterinary health company offering point-of-care diagnostics and therapeutic products

Ann arborUnited statesKostenloser wertpapierhandelLarry heatonAssisi animal healthZomedica corpZomedica corp viewChief executive officerPulse veterinary technologiesCalmer canineSmall animal veterinariansAnimal veterinarianThird quarterOutstanding shareRelations contact